Current concepts in psoriatic arthritis: pathogenesis and management

Area of Science:

• Immunodermatology
• Rheumatology
• Inflammation research

Background:

• Psoriatic arthritis (PsA) affects a subset of psoriasis patients, presenting common pathophysiological mechanisms with skin symptoms.
• Abnormal innate and adaptive immune responses in psoriasis may target joints after environmental triggers in susceptible individuals.
• PsA exacerbates cardiovascular risk associated with psoriasis, linked to systemic inflammation and atherogenesis.

Purpose of the Study:

• To explore the shared immune mechanisms between psoriasis and psoriatic arthritis.
• To highlight the role of specific inflammatory pathways, such as tumor necrosis factor (TNF) and interleukin-17A (IL-17A), in PsA.
• To inform dermatologists on current research for improved patient treatment strategies.

Main Methods:

• Review of basic research findings.
• Analysis of clinical trial data.
• Investigation of immune cell involvement (e.g., Th17 cells).

Main Results:

• Evidence suggests shared immune pathways in psoriasis and PsA.
• Tumor necrosis factor (TNF) is implicated in PsA pathophysiology.
• Th17 cells and IL-17A are increasingly recognized as important factors in PsA.

Conclusions:

• Understanding PsA pathophysiology, including immune responses and inflammatory mediators, is crucial.
• Research into TNF and IL-17A pathways offers therapeutic targets for PsA.
• Enhanced knowledge of PsA mechanisms supports better clinical decision-making for dermatologists.